As LY-CoV555 advances into Phase 3 COVID-19 prevention studies, AbCellera’s COVID-19 database reaches over 2,000 new antibodies against the virus, discovered from recovered patient samples August 3, 2020 VANCOUVER, British… Read More
July 29, 2020 AbCellera is celebrating a double win: the company has been named on Fast Company’s prestigious annual list of Best Workplaces for Innovators. Additionally, AbCellera has been awarded… Read More
VANCOUVER, British Columbia, Aug. 06, 2020 (GLOBE NEWSWIRE) — A novel strategy has been developed by Novateur Ventures, which provides new hope in battle against COVID-19. The study titled ‘A… Read More
SEATTLE, Aug. 06, 2020 (GLOBE NEWSWIRE) — Neoleukin Therapeutics, Inc., “Neoleukin” (NASDAQ:NLTX), a biopharmaceutical company utilizing sophisticated computational methods to design de novo protein therapeutics, today announced that management will participate in… Read More
August 5, 2020 – Ottawa, Ontario The Government of Canada is aggressively pursuing the purchase and development of COVID-19 vaccines, treatments and related supplies to protect Canadians and is working… Read More
